ProCE Banner Activity

CE / CME

2023 Update: Practical Case Studies in Outpatient COVID-19 Management

Video

Hear faculty experts discuss case-based management strategies for nonhospitalized patients with COVID-19.

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit 

Released: May 02, 2023

Expiration: November 01, 2023

No longer available for credit.

Share

Faculty

Tracey Piparo

Tracey Piparo, PA-C

Department of Palliative Medicine
RJWBarnabas
New Brunswick, New Jersey

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Trinh P. Vu

Trinh P. Vu, PharmD, BCIDP

Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmacy
Emory University Hospital Midtown
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange and ProCE, LLC

ProCE Banner

Supporters

Supported by educational grants from and Gilead Sciences, Inc. and Merck Sharp & Dohme Corp.

Gilead Sciences, Inc.

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner

Target Audience

This program is intended for physicians, nurse practitioners, nurses, pharmacists, and other healthcare professionals involved in the management of patients with COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize early outpatient COVID-19 management.

Program Learning Goal

The goal of this activity is to improve healthcare professionals’ knowledge and competence and foster an interprofessional approach for early SARS-CoV-2 diagnosis and treatment in the outpatient setting to mitigate severe and long-term consequences of COVID-19.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify candidates for early outpatient treatment with SARS‑CoV‑2 antivirals based on determinants associated with adverse outcomes including risk factors for severe illness and health disparities

  • Select the appropriate antiviral treatment for patients with COVID-19 based on patient factors, guidelines, and current scientific evidence
  • Apply strategies to promote timely and equitable administration of SARS-CoV-2 antivirals

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Tracey Piparo, PA-C

Department of Palliative Medicine
RJWBarnabas
New Brunswick, New Jersey

Tracey Piparo, PA-C, has no relevant financial relationships to disclose.

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: unrestricted research grant: Gilead.

Trinh P. Vu, PharmD, BCIDP

Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmacy
Emory University Hospital Midtown
Atlanta, Georgia

Trinh P. Vu, PharmD, BCIDP, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, and ProCE, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from May 02, 2023, through November 01, 2023:

1. Login or Sign Up for an account by clicking at the top of this page.
2. Read the target audience, learning objectives, and faculty disclosures.
3. View and study the content in its entirety.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, and Practicing Clinicians Exchange. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-23-124-H01-P

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.